Dr. Bala Manian

BalaManian.jpg (45045 bytes)Dr. Manian is the current chairman of EPPIC.  A serial enterprenuer, he has founded of a long list of biotechnology and instrumentation companies   including  Biometric Imaging Inc, Surromed, QDOT, Entigen, Biometric imaging, Lumisys, Molecular Dynamics, and Digital Optics Corp.

Presently Dr. Manian is involved with Surromed, Q DOT Corporation, and Entigen.  Previosly he was the founder-chairman of Biometric Imaging Inc, a systems company dedicated to advancing cellular therapeutics, which has since been acquired by medical device giant Becton Dickinson & Co. Prior to founding Biometric Imaging, Dr. Manian founded both Lumisys and Molecular Dynamics in 1987. Lumisys manufactures and markets Tele-radiology systems to the medical imaging market. Molecular Dynamics, manufactures and markets analytical instrumentation systems to molecular biology and genetic engineering research. Both Lumisys (LUMI) and Molecular Dynamics (MDYN) went public on the NASDAQ before their acquisition by Eastman Kodak and Amersham Pharmacia Biotech, respectively.  Dr. Manian founded Digital Optics Corp in 1980, an optical instrumentation and systems development company that was acquired by Matrix Corp in 1984.
An expert in the design of electro-optical systems, Dr. Manian holds more than 30 patents, many of which have resulted in successful commercial products. Additionally, Dr. Manian has authored more than 35 scientific publications. He has a B.S. in Physics from the University of Madras, an M.S in Applied Optics from the University of Rochester, and a Ph.D in Mechanical Engineering from Purdue Universiy. He has been a Faculty Member at the University of Rochester's Institute of Optics for four years, teaching courses in optical fabrication and testing, optical instrumentation and holography. Dr. Manian left the institute in 1974 to pursue commercial opportunities.

Dr.  Manian has been recognized by the award of an "Academy Certificate" from the Academy of Motion Picture Arts and Sciences for inventing the special effects technology used in movies like "Return of the Jedi" and the Indiana Jones Trilogy.  The technology developed by Bala Manian, David DiFrancesco and Thomas Noggle, at Digital Optics Corp., and transferred to Lucas film Ltd. in 1983, allowed filmmakers to insert special effects into movies using computerized digital imaging.   This was a considerable improvement over existing technology, which involved an expensive and painstaking procedure whereby two different sets of images, almost two movies, had to be created and combined to achieve the same special effects.

Gans Ganapati, MBA

A Co-Founder and Business Development Director of Triesta Sciences, Gans has nearly 15 years of venture development, business management and M&A experience in the life sciences and technology industries whilst at CSFB in New York and the West Coast and at Tata Industries Limited in India.

Mohan Uttarwar

As President and Chief Executive Officer of Bioimagene, Mohan is responsible for the companyís strategic direction and day-to-day operations. Prior to co-founding BioImagene, Mohan was cofounder of Roamware Inc and was president and founder of SoftPlus, a leading provider of eCRM software for telecom carriers around the world. In February 2000, SoftPlus was sold to US Interactive for $360 million. Prior to that, Mohan co-founded and served as president of Digital Tools, Inc., a leader in enterprise project and resource management software. Before Digital Tools he held various software development and management positions with Hewlett Packard and Intel. Mohan has more than 20 years of experience as a high-tech executive and entrepreneur.

Mohan earned a masterís degree of science in computer science from the Florida Institute of Technology, and a masterís degree of science in electrical engineering from Bombay, India. He has participated in several executive management programs at Stanford University and is a charter member of TiE (The Indus Entrepreneurs), the Silicon Valley-based forum for entrepreneurs.

Sumir Chadha

Sumir Chahda is currently Senior Managing Director of WestBridge Partners.  Prior to founding WestBridge, Sumir was a key member of the Principal Investment Area at Goldman, Sachs & Co, based in New York and Singapore, focused on venture investments in technology. He led or was a key member of the investment team for over 17 technology companies including high profile success stories such as Storage Networks (NASDAQ: STOR), FreeMarkets (NASDAQ: FMKT), webMethods (NASDAQ: WEBM), Centra (NASDAQ: CTRA), Ventro/Chemdex (NASDAQ: VNTR) and TechSpan. These investments totaled over $140 million of private equity capital.

His career began as a management consultant at McKinsey & Co. based in New York and New Delhi, where he specialized in the Internet and wireless industries.  Sumir is the Chairman of the US-India Venture Capital Association and also a Charter Member of The Indus Entrepreneurs (TiE)'s Silicon Valley chapter.

Sumir received an MBA with distinction from Harvard University and a BSE in Computer Science from Princeton University

Rajiv P. Patel

Mr. Patel is a Partner at Fenwick and West, as part of the Intellectual Property Group.  He represents companies from privately held start-ups to publicly traded corporations on a wide variety of complex intellectual property issues and matters. Mr. Patel counsels companies on patent portfolio development and management strategies, patent enforcement strategies, and patent and high technology licensing agreements, and strategies. Mr. Patel also leads intellectual property audits to help companies identify key intellectual assets and evaluate protection options for such assets.

Mr. Patel has legal, technical, and business experience representing companies in high technology areas that include wireless communications, electronics, complex computer hardware architecture, complex software architecture, electro-mechanical devices, and nanotechnology applications. Mr. Patel also has legal, technical and business experience representing technology think-tanks and traditional non-technology companies for patent and other intellectual property matters.

Ralph Pias

Ralph Pias is a Partner at Fenwick and West, as part of the Intellectual Property GroupMr. Pais' practice is in the broad area of technology-related transactions, including licensing, technology development agreements, strategic alliances and distribution agreements. In addition, he works on the intellectual property aspects of significant corporate transactions such as mergers, acquisitions and spin-outs. In his practice, Mr. Pais represents clients across the broad spectrum of Silicon Valley business activities, including semiconductor manufacturing design and related tools, equipment and design software, online service providers and market places, enterprise and consumer software products, life sciences and health care. In addition, Mr. Pais is responsible for leading the firm's international practice activities and he has extensive experience assisting U.S. companies expanding their business activities in other parts of the world, and representing non-U.S. entities establishing activities in Silicon Valley.